During the last session, Caredx Inc (NASDAQ:CDNA)’s traded shares were 0.58 million, with the beta value of the company hitting 1.87. At the end of the trading day, the stock’s price was $22.34, reflecting an intraday loss of -4.65% or -$1.09. The 52-week high for the CDNA share is $34.84, that puts it down -55.95 from that peak though still a striking 66.79% gain since the share price plummeted to a 52-week low of $7.42. The company’s market capitalization is $1.20B, and the average intraday trading volume over the past 10 days was 1.05 million shares, and the average trade volume was 785.80K shares over the past three months.
Caredx Inc (CDNA) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.89. CDNA has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.12.
Caredx Inc (NASDAQ:CDNA) trade information
Caredx Inc (CDNA) registered a -4.65% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -4.65% in intraday trading to $22.34, hitting a weekly high. The stock’s 5-day price performance is 1.27%, and it has moved by 8.39% in 30 days. Based on these gigs, the overall price performance for the year is 124.07%. The short interest in Caredx Inc (NASDAQ:CDNA) is 3.97 million shares and it means that shorts have 5.6 day(s) to cover.
The consensus price target of analysts on Wall Street is $37.5, which implies an increase of 40.43% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $35 and $40 respectively. As a result, CDNA is trading at a discount of -79.05% off the target high and -56.67% off the low.
Caredx Inc (CDNA) estimates and forecasts
Statistics show that Caredx Inc has outperformed its competitors in share price, compared to the industry in which it operates. Caredx Inc (CDNA) shares have gone up 21.28% during the last six months, with a year-to-date growth rate more than the industry average at 167.19% against 6.70. In the rating firms’ projections, revenue will increase 18.36% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 84M as predicted by 4 analyst(s). Meanwhile, a consensus of 4 analyst(s) estimates revenue growth to 86.01M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 65.57M and 72.05M respectively. In this case, analysts expect current quarter sales to grow by 28.11% and then jump by 19.38% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -21.96%. While earnings are projected to return 76.60% in 2025.
CDNA Dividends
Caredx Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Caredx Inc (NASDAQ:CDNA)’s Major holders
Caredx Inc insiders own 3.45% of total outstanding shares while institutional holders control 96.41%, with the float percentage being 99.86%. ARK INVESTMENT MANAGEMENT LLC is the largest shareholder of the company, while 304.0 institutions own stock in it. As of 2024-06-30, the company held over 5.7 million shares (or 10.925% of all shares), a total value of $88.56 million in shares.
The next largest institutional holding, with 5.29 million shares, is of BLACKROCK INC.’s that is approximately 10.1283% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $82.1 million.
Also, the Mutual Funds coming in first place with the largest holdings of Caredx Inc (CDNA) shares are ARK ETF Tr-ARK Genomic Revolution ETF and Vanguard Total Stock Market Index Fund . Data provided on Nov 30, 2024 indicates that ARK ETF Tr-ARK Genomic Revolution ETF owns about 2.59 shares. This amounts to just over 4.82 percent of the company’s overall shares, with a $57.81 million market value. The same data shows that the other fund manager holds slightly less at 1.52, or about 2.83% of the stock, which is worth about $33.9 million.
